Change search
Link to record
Permanent link

Direct link
Publications (4 of 4) Show all publications
Król, S., Kovalova, T., Janczak, M., Kalsum, S., Akber, M., Högbom, M., . . . Brzezinski, P. (2026). Mycobacterial respiratory chain enzymes and growth are inhibited by decylubiquinone. Communications Biology, 9, Article ID 43.
Open this publication in new window or tab >>Mycobacterial respiratory chain enzymes and growth are inhibited by decylubiquinone
Show others...
2026 (English)In: Communications Biology, E-ISSN 2399-3642, Vol. 9, article id 43Article in journal (Refereed) Published
Abstract [en]

Aerobic organisms obtain energy by linking electron transfer from NADH to O2, through the respiratory chain, to transmembrane proton translocation. In mycobacteria the respiratory chain is branched; the membrane-bound electron carrier menaquinol (MQH2) donates electrons either to the O2-reducing cytochrome bd or a supercomplex that is composed of a complex (C) III2 dimer flanked by two CIVs. Here, we measured the dimethyl-naphthoquinone (DMNQH2, a menaquinol analogue) oxidation:O2 reduction activities of the CIII2CIV2 supercomplex and cytochrome bd in the presence of an analogue (decylubiquinone, DCQ) of the mammalian electron carrier, ubiquinol. The data show that DCQH2 inhibits both the CIII2CIV2 and cytochrome bd activities, suggesting that DCQ/DCQH2 interferes with both branches of the respiratory chain. Cryo-EM data of the M. smegmatis supercomplex shows that oxidized DCQ binds in the electron donor site (Qo) of CIII2. Accordingly, growth of M. smegmatis cells was impaired in the presence of DCQ. Remarkably, DCQ also impairs intracellular growth of virulent M. tuberculosis cells in human primary macrophages suggesting that the compound could potentially be used as an adjuvant during tuberculosis disease treatment.

National Category
Biochemistry
Identifiers
urn:nbn:se:su:diva-252273 (URN)10.1038/s42003-025-09309-9 (DOI)001657997900001 ()41372535 (PubMedID)2-s2.0-105027058918 (Scopus ID)
Available from: 2026-02-10 Created: 2026-02-10 Last updated: 2026-05-05Bibliographically approved
Kovalova, T., Janczak, M., Gamiz-Hernandez, A. P., Lundin, D., Sharma, S., Vilhjálmsdóttir, J., . . . Ädelroth, P. (2026). The Mycobacterium smegmatis bd-II terminal oxidase employs a carboxylate shift mechanism. Proceedings of the National Academy of Sciences of the United States of America, 123(11), Article ID e2515348123.
Open this publication in new window or tab >>The Mycobacterium smegmatis bd-II terminal oxidase employs a carboxylate shift mechanism
Show others...
2026 (English)In: Proceedings of the National Academy of Sciences of the United States of America, ISSN 0027-8424, E-ISSN 1091-6490, Vol. 123, no 11, article id e2515348123Article in journal (Refereed) Published
Abstract [en]

Cytochrome bd is a terminal oxidase expressed under low oxygen conditions and central for the survival of many pathogens. Here, we characterize the cyt bd-II from Mycobacterium smegmatis, a member of a hitherto uncharacterized evolutionary group (qOR-2) of bd oxidases, by combining biochemical studies with cryo-electron microscopy (cryo-EM), and multiscale simulations. Overexpressing the appCB operon in its native host led to production of a highly active bd-II (kobs = 30 e s−1) that together with a high-resolution (2.8 Å) cryo-EM structure and multiscale simulations reveal unique proton pathways and oxygen channels responsible for its function. We propose that a pH-dependent molecular switch, involving coordination changes of heme d and surrounding bulky residues regulate substrate access into the active site. Taken together, our findings provide detailed mechanistic insight of qOR-2 type bd oxidases, and a basis for understanding the evolution of the superfamily.

Keywords
bacterial bioenergetics, molecular dynamics, respiration, structural biology
National Category
Structural Biology
Identifiers
urn:nbn:se:su:diva-253841 (URN)10.1073/pnas.2515348123 (DOI)001729135500001 ()41805574 (PubMedID)2-s2.0-105032786201 (Scopus ID)
Available from: 2026-03-31 Created: 2026-03-31 Last updated: 2026-05-05Bibliographically approved
Kovalova, T., Król, S., Gamiz-Hernandez, A. P., Sjöstrand, D., Kaila, V. R. I., Brzezinski, P. & Högbom, M. (2024). Inhibition mechanism of potential antituberculosis compound lansoprazole sulfide. Proceedings of the National Academy of Sciences of the United States of America, 121(47), Article ID e2412780121.
Open this publication in new window or tab >>Inhibition mechanism of potential antituberculosis compound lansoprazole sulfide
Show others...
2024 (English)In: Proceedings of the National Academy of Sciences of the United States of America, ISSN 0027-8424, E-ISSN 1091-6490, Vol. 121, no 47, article id e2412780121Article in journal (Refereed) Published
Abstract [en]

Tuberculosis is one of the most common causes of death worldwide, with a rapid emergence of multi-drug-resistant strains underscoring the need for new antituberculosis drugs. Recent studies indicate that lansoprazole—a known gastric proton pump inhibitor and its intracellular metabolite, lansoprazole sulfide (LPZS)—are potential antituberculosis compounds. Yet, their inhibitory mechanism and site of action still remain unknown. Here, we combine biochemical, computational, and structural approaches to probe the interaction of LPZS with the respiratory chain supercomplex III2IV2 of Mycobacterium smegmatis, a close homolog of Mycobacterium tuberculosis supercomplex. We show that LPZS binds to the Qo cavity of the mycobacterial supercomplex, inhibiting the quinol substrate oxidation process and the activity of the enzyme. We solve high-resolution (2.6 Å) cryo-electron microscopy (cryo-EM) structures of the supercomplex with bound LPZS that together with microsecond molecular dynamics simulations, directed mutagenesis, and functional assays reveal key interactions that stabilize the inhibitor, but also how mutations can lead to the emergence of drug resistance. Our combined findings reveal an inhibitory mechanism of LPZS and provide a structural basis for drug development against tuberculosis.

National Category
Biochemistry Molecular Biology
Research subject
Biochemistry
Identifiers
urn:nbn:se:su:diva-227927 (URN)10.1073/pnas.2412780121 (DOI)001369291200014 ()39531492 (PubMedID)2-s2.0-85209480526 (Scopus ID)
Available from: 2024-04-03 Created: 2024-04-03 Last updated: 2025-03-18Bibliographically approved
Riepl, D., Gamiz-Hernandez, A. P., Kovalova, T., Król, S. M., Mader, S. L., Sjöstrand, D., . . . Kaila, V. R. I. (2024). Long-range charge transfer mechanism of the III2IV2 mycobacterial supercomplex. Nature Communications, 15, Article ID 5276.
Open this publication in new window or tab >>Long-range charge transfer mechanism of the III2IV2 mycobacterial supercomplex
Show others...
2024 (English)In: Nature Communications, E-ISSN 2041-1723, Vol. 15, article id 5276Article in journal (Refereed) Published
Abstract [en]

Aerobic life is powered by membrane-bound redox enzymes that shuttle electrons to oxygen and transfer protons across a biological membrane. Structural studies suggest that these energy-transducing enzymes operate as higher-order supercomplexes, but their functional role remains poorly understood and highly debated. Here we resolve the functional dynamics of the 0.7 MDa III2IV2 obligate supercomplex from Mycobacterium smegmatis, a close relative of M. tuberculosis, the causative agent of tuberculosis. By combining computational, biochemical, and high-resolution (2.3 Å) cryo-electron microscopy experiments, we show how the mycobacterial supercomplex catalyses long-range charge transport from its menaquinol oxidation site to the binuclear active site for oxygen reduction. Our data reveal proton and electron pathways responsible for the charge transfer reactions, mechanistic principles of the quinone catalysis, and how unique molecular adaptations, water molecules, and lipid interactions enable the proton-coupled electron transfer (PCET) reactions. Our combined findings provide a mechanistic blueprint of mycobacterial supercomplexes and a basis for developing drugs against pathogenic bacteria.

National Category
Biochemistry Molecular Biology
Identifiers
urn:nbn:se:su:diva-232604 (URN)10.1038/s41467-024-49628-9 (DOI)001252057400022 ()38902248 (PubMedID)2-s2.0-85196509810 (Scopus ID)
Funder
Knut and Alice Wallenberg Foundation, 2019.0251Swedish Research Council
Available from: 2024-08-20 Created: 2024-08-20 Last updated: 2025-02-20Bibliographically approved
Organisations
Identifiers
ORCID iD: ORCID iD iconorcid.org/0000-0002-0144-2463

Search in DiVA

Show all publications